Petros Pharmaceuticals Inc - PTPI Earnings per share for the trailing year

Petros Pharmaceuticals Inc (PTPI) - corporate logo

Petros Pharmaceuticals (PTPI) is expanding Stendra sales and digital services for the B2B segment. However, generic competition and marketing costs for new products are limiting potential. High customer acquisition costs online are reducing overall profitability. The value of 0.00 shapes the current metric, which clearly demonstrates the historical YoY EPS growth over the last 12 months on this chart.

petrospharma.com (PTPI): Earnings per share for the last twelve months from 02/11/2024 to 02/20/2024

Petros Pharmaceuticals Inc - analytical breakdowns and key metrics (PTPI)

- issuer market value details:
Fundamental valuation:Petros Pharmaceuticals Inc (PTPI)
Brand item of Petros Pharmaceuticals, Inc.

Net income per share dynamics determine the fundamental stability of the business. This metric measures the percentage change in trailing twelve-month (TTM) income, neutralizing the seasonal fluctuations of quarterly reporting. By analyzing the TTM EPS growth chart, an investor can see the real return on assets. For Petros Pharmaceuticals (PTPI), this trend confirms the efficiency of its digital platforms. Direct online sales allow the company to scale profits without a proportional increase in operating expenses.

Competitor analysis

Earnings per share for the trailing year HLN (Haleon)|KVUE: Net earnings per share (EPS TTM)|Verona Pharma Corp - Earnings per share for the trailing year|MENS (Jyong Biotech Limited) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months ligand.com LGND|Earnings per share for the last twelve months Amneal (AMRX)|PRGO (Perrigo Company PLC) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ALVO (Alvotech S.A.)|Liquidia Technologies - Earnings per share for the last twelve months|Galapagos Corp - Net earnings per share (EPS TTM)|ANIP (ANI Pharmaceuticals) - Earnings per share for the last 12 months|MannKind Corp. (MNKD) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AMPH (Amphastar Pharmaceuticals, Inc.)|PCRX (Pacira Corp) - Net earnings per share (EPS TTM)|SPRY: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TBPH|Net earnings per share for the last four quarters Aquestive Therapeutics, Inc.|Earnings per share for the last twelve months scPharmaceuticals Inc. SCPH|TECX: Earnings per share for the last 12 months|TNXP - Earnings per share for the last twelve months|Net earnings per share for the last four quarters SXT Pharmaceuticals SXTC|EPRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months bioharvest.com (BHST)|Net earnings per share for the last 12 months EXOZ|ORMP: Earnings per share for the trailing year|Earnings per share for the last twelve months Entera Bio Ltd. (ENTX)|HYFT (MindWalk Therapeutics) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) ABVC (ABVC BioPharma, Inc)|Earnings per share for the trailing year CPIX|QNTM - Earnings per share for the last twelve months|FibroGen Corp (FGEN) - Net earnings per share for the last 12 months|Telomir Pharmaceuticals Corp (TELO) - Earnings per share for the last twelve months|Rani Therapeutics (RANI) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Synergy CHC Corp.|Net earnings per one share for the last twelve months rallybio.com RLYB|Net earnings per share (EPS TTM) LEXX|PULM: Earnings per one share for the last 12 months|Pheton Holdings Ltd - Net earnings per share for the last 12 months|APM - Net earnings per share for the last 12 months|LYRA - Earnings per share for the last twelve months|Earnings per share for the trailing year IBO (Impact BioMedical)|TNF Pharmaceuticals Inc. (TNFA) - Earnings per share for the last twelve months|cbdMD Corp - Earnings per share for the trailing year|Net earnings per share for the last 12 months PRFX|Altamira Therapeutics (CYTO) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) LIPO|Net earnings per share (EPS TTM) optinose.com (OPTN)|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Net earnings per one share for the last twelve months|Qilian International Corp - Net earnings per share (EPS TTM)|ACELYRIN, Inc. (SLRN) - Net earnings per share for the last 12 months|TFF Pharma (TFFP) - Earnings per share for the last twelve months